Karjalainen, J. M., Tammi, R. H., Tammi, M. I., Eskelinen, M. J., Ågren, U. M., Parkkinen, J. J., . . . Kosma, V. (2000). Reduced Level of CD44 and Hyaluronan Associated with Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma. American Society for Investigative Pathology.

Karjalainen, Jari M., Raija H. Tammi, Markku I. Tammi, Matti J. Eskelinen, Ulla M. Ågren, Jyrki J. Parkkinen, Esko M. Alhava, and Veli-Matti Kosma. Reduced Level of CD44 and Hyaluronan Associated With Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma. American Society for Investigative Pathology, 2000.

Karjalainen, Jari M., et al. Reduced Level of CD44 and Hyaluronan Associated With Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma. American Society for Investigative Pathology, 2000.